The FDA conducted inspections at three biologics companies in Maine during 2025, according to the U.S. Food and Drug Administration (FDA).
These inspections represented the second highest count for a specific company type inspected by the FDA in Maine, accounting for 3.7% of all inspections conducted that year.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety and quality.
| Project Area | No Action Indicated | Voluntary Action Indicated | Official Action Indicated |
|---|---|---|---|
| Blood and Blood Products | 2 | — | — |
| Colors and Cosmetics Technology | 1 | — | — |
| Compliance: Devices | — | 1 | — |
| Food Composition, Standards, Labeling and Econ | 1 | 1 | — |
| Foodborne Biological Hazards | 56 | 13 | — |
| Human Cellular, Tissue, and Gene Therapies | 1 | — | — |
| Monitoring of Marketed Animal Drugs, Feed, and Devices | 2 | — | — |
| Postmarket Assurance: Devices | 1 | — | — |
| Technical Assistance: Food and Cosmetics | 7 | 2 | — |
